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Abstract: Carotid disease is a common finding in patients with coronary artery disease (CAD)
and its presence is associated with worse clinical outcomes. Intima-media thickness provides
incremental value over traditional risk factors in predicting cardiovascular events; however, it
does not predict the absence of CAD or its extent and severity. The presence of carotid plaques
is associated with an increased risk of cardiovascular events in patients with CAD regardless
of the treatment strategy (medical therapy alone or myocardial revascularization). Hence, we
advocate the screening of patients with diagnosed CAD for carotid atherosclerosis. The
prognostic impact of ultrasound characteristics of carotid plaques on cardiovascular outcomes
of patients with CAD remains controversial.
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Introduction
The coexistence of carotid and coronary artery disease (CAD) is a challenge to
cardiologists, vascular and cardiothoracic surgeons, and neurologists. Patients with
coexistent narrowing of carotid and coronary arteries represent a particularly high-
risk group and to date there has been no consensus with regard to their management.
Carotid endarterectomy in these patients is associated with an increased incidence of
perioperative myocardial infarction (Biller et al 1998), and coronary artery bypass
grafting is accompanied by an elevated risk of neurological injury (Jones et al 1984).
Epidemiological data
While in a general adult population the prevalence of carotid stenosis approaches
4% (Mathiesen, Joakimsen, et al 2001), in patients with coronary artery disease it
can reach 30%–70% (Kallikazaros et al 1999; Held et al 2001; Komorovsky et al
2004; Lombardo et al 2004). For those undergoing coronary artery bypass grafting,
the prevalence of > 50% narrowing of at least one internal carotid artery is thought
to be around 20%, and > 70% carotid stenosis is found in 2%–12% of cases (Schwartz
et al 1995; Evangelopoulos et al 2000).
Carotid artery disease as a marker of increased
risk of cardiovascular events
Carotid artery disease, even in its preclinical stage (intima-media thickness [IMT]
≥ 1 mm and non-obstructive [< 50%] carotid plaques), has been associated with CAD
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Intima-media thickness
For the far (posterior) wall of the carotid artery, this index
can be easily measured by ultrasound as the distance
between the leading edge of the luminal echo (first bright
line) and the leading edge of the media-adventitia echo
(second bright line). For the near (anterior) wall, IMT is
measured as the distance between the trailing edge of the
first bright line and the trailing edge of the second bright
line (Pignoli et al 1986; Iglesias del Sol 2001). In clinical
trials, IMT has been used as a surrogate end point for
evaluating the progression of atherosclerosis (de Groot et
al 1998; Pitt et al 2000).
The use of IMT for assessment of cardiovascular event
risk has, however, a number of limitations. Although IMT
has been shown to be a strong predictor of incident
myocardial infarction in overall population aged ≥ 55 years
(van der Meer et al 2004), and there is a good correlation
between increased IMT and the presence of CAD, IMT is
not a good predictor of its extent and severity and cannot
predict the absence of significant CAD. Furthermore, IMT
does not appear to have predictive value in populations with
high prevalence of CAD, or in younger age groups where
the prevalence is low (Adams et al 1995; Held et al 2001).
Therefore, the American Heart Association Prevention V
Conference (Greenland et al 2000) did not recommend
routine IMT measurements in patients with low or high risk
of cardiovascular disease, but stated that this may be
appropriate in patients at intermediate risk of CAD (based
on Framingham risk assessment). This means that if in a
patient at intermediate risk of coronary event (6%–20% risk
in 10 years) the carotid IMT of ≥ 1 mm is detected, he/she
may be stratified as a high-risk patient and receive high-
risk treatment accordingly.
The assessment of IMT in various laboratories is not
standardized. In some studies only the common carotid
artery IMT has been considered (Held et al 2001; Cuomo et
al 2002), in others, along with the common carotid artery
IMT, the IMT in carotid bifurcation (bulb), and internal
carotid artery has been measured (Iglesias del Sol et al 2001).
Thereafter the results have been either averaged (Haluska
et al 2004; Yildiz et al 2004) or the greatest IMT values
have been used for analysis (Iglesias del Sol A et al 2001;
Crouse et al 2002). These methodological differences limit
the interpretation of results. Moreover, a relatively large
proportion of variation in repeated measurements over time
is likely to be due to measurement error. Most studies
suggest, however, that the common carotid artery is the
preferable site for the measurement of IMT because it is
tubular and can be aligned perpendicular to the transducer
beam. Reproducibility and yield of the common carotid
artery IMT is therefore superior to that of IMT of the carotid
bifurcation or internal carotid artery (Howard et al 1993;
Crouse et al 1995).
Recent consensus (Touboul et al 2004) concluded that
there is no need “to treat” IMT values or to monitor IMT
values in individual patients. IMT measurements are not
recommended to predict events on an individual level, but
may be used in clinical trials as a surrogate end point on a
group level. The recommended standardized methods for
IMT measurements are supposed to improve the power of
studies incorporating IMT values and to facilitate the
merging of databases for meta-analyses.
Carotid plaques
Carotid plaques in various studies have been defined either
as distinct areas “with an IMT exceeding twice that of
neighboring sites” (Held et al 2001, p 64) or “focal
widenings of the vessel wall of > 50% relative to adjacent
segments” (Hollander et al 2002, p 2873), or a “lesion with
a focal IMT of 1.1 mm or more, with a localized protrusion
of the vessel wall into the lumen (Honda et al 2004, p 1178).
In another study, a cut-off point of 1.3 mm was used for a
focal thickening of the IMT complex to be considered as a
plaque (Kablak-Ziembicka et al 2004). According to the
consensus statement (Touboul et al 2004), a plaque is defined
as a focal structure that encroaches into the arterial lumen
of at least 0.5 mm or 50% of the surrounding IMT value or
demonstrates a thickness of ≥ 1.5 mm as measured from the
media-adventitia interface to the intima-lumen interface.
Obstructive plaques (causing > 50% lumen diameter
narrowing) cause blood flow acceleration at the stenosis site
and a peak systolic velocity > 125 cm/sec in the internal
carotid artery is an indicator of its hemodynamically
significant narrowing (Grant et al 2003). The presence of
obstructive carotid plaques is associated with increasing risk
of cerebrovascular events by atheroembolism, as the severity
of the stenosis increases (NASCET 1991), and increased
risk of cardiac death and myocardial infarction (Held et al
2001).
The risk associated with the presence of non-obstructive
carotid plaques remains a controversial problem. Like IMT,
these plaques reflect the overall atherosclerotic burden, and,
as compared with IMT, better predict cardiovascular death
and nonfatal myocardial infarction (Held et al 2001).Vascular Health and Risk Management 2005:1(2) 133
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The risk of ischemic events related to carotid plaques is
also much associated with their histological morphology.
Plaque echogenicity as assessed by B-mode ultrasound has
been shown to correlate with histological findings.
Echolucent plaques consist of a thin fibrous echogenic cap
overlying a lipid core with high macrophage content and,
sometimes, zones of hemorrhage. When the cap is thinner
than 5–10 µ it may not be detected by ultrasound. Echogenic
plaques consist of dense fibrous tissue and their echogenicity
increases with increasing amounts of collagen. The presence
of calcifications results in high echoes in corresponding
areas with acoustic shadowings (Goes et al 1990; ECPS
Group 1995). Several classifications have been proposed to
group carotid plaques according to their appearance on
ultrasound (Table 1).
Echolucent and heterogeneous plaques are described as
the most vulnerable, rupture-prone lesions and have been
associated with neurovascular symptoms and an increased
risk of ischemic stroke (Polak et al 1998; Grønholdt,
Norderstgaard, et al 2001; Mathiesen, Bønaa, et al 2001;
Tegos et al 2001). Echogenic plaques are most frequently
associated with asymptomatic status (AbuRahma et al 2002).
In a general population, the ratio of subjects with echolucent
plaques to subjects with echogenic plaques is approximately
1:2 (Joakimsen et al 1999; Zureik et al 2003). Ecolucent
plaques dominate in patients with symptomatic carotid
disease, while asymptomatic patients usually have echogenic
plaques (Steffen et al 1989). It should be noted, however,
that carotid plaques are dynamic structures that change in
composition over a period of time. Patients with recent
symptoms are more likely to have echolucent plaques
compared with patients with earlier symptoms (ECPS 1995).
In patients evaluated for chest pain and in those with
acute coronary syndromes, there is a stepwise increase in
the number with carotid disease with the increasing severity
of CAD (Kallikazaros et al 1999; Komorovsky et al 2005).
A gradual increase in the proportion of echogenic carotid
plaques was observed with the increase of the extent of CAD,
while the proportion of echolucent carotid plaques remained
unchanged (Figure 1) (Komorovsky et al 2005). This could
reflect the natural development of more organized and
calcified plaques in more advanced stages of atherosclerosis.
Recently, Lombardo et al (2004) classified carotid
plaques as complex (those with irregular surface and/or
heterogeneous echogenicity involving > 50% of the plaque
area, including echolucent, mobile, and ulcerated plaques)
and simple (plaques with smooth surface and a homo-
geneous hyperechoic structure involving > 50% of the plaque
area). They demonstrated that complex carotid plaques are
more prevalent in patients with unstable angina pectoris
Table 1 Ultrasonographic classifications of carotid plaques
Gray-Weale (1988) and
Geroulakos (1993) Johnson (1985) Reilly (1983) ECPS (1995)
Type 1: predominantly echolucent Soft (low level echoes) Heterogeneous (high, medium, Ecolucent heterogeneous
with a thin echorich cap and low level echoes)
Type 2: dominantly echolucent lesions Soft (low level echoes) Heterogeneous (high, medium, Ecolucent heterogeneous
with small areas of echogenicity and low level echoes)
Type 3: dominantly echogenic lesions Dense (high level echoes) Heterogeneous (high, medium, Intermediate
with small (< 25%) areas of echolucency and low level echoes)
Type 4: echorich homogeneous Dense (high level echoes) Homogeneous (medium or high Echorich homogeneous
level echoes)
Type 5: plaques with acoustic shadowing Calcified Homogeneous (medium or high Echorich homogeneous
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Figure 1 Distribution of echolucent and echogenic carotid plaques according
to the extent of coronary artery disease in the entire study population. Data
adapted from Komorovsky et al (2005). Abbreviations: VD, vessel disease.
NOTE: black bars = echogenic carotid plaque group; white bars = echolucent
carotid plaque group.Vascular Health and Risk Management 2005:1(2) 134
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compared with patients with stable angina. As in a general
population, the ratio between complex and simple carotid
plaques in patients with CAD is approximately 1:2
(Lombardo et al 2004); however, this ratio seems to grow
with the increasing instability of patients due to the increased
prevalence of complex carotid plaques (Lombardo et al
2004). These results are complementary to the recent
findings, which showed that acute coronary syndrome
patients with multiple complex coronary plaques had more
either echolucent or echogenic carotid plaques and carotid
calcifications compared with patients who only had a single
complex coronary plaque (Kato et al 2003).
The prognostic relevance of ultrasound characteristics
of carotid plaques for cardiovascular events is somewhat
controversial. In one of the studies it was demonstrated that
in patients undergoing endarterectomy because of > 50%
or > 70% stenosis, the echolucency of the removed carotid
plaques was associated with the risk of myocardial infarction
and stroke combined (Liapis et al 2002). Another study
showed that a combined end point of death, myocardial
infarction, or stroke was significantly more frequent in
hypertensive patients with echolucent carotid plaques
compared with comparable patients with echo-rich carotid
plaques. Moreover, the multiple risk intervention program
was beneficial in patients with echolucent carotid plaques,
but not in those with echogenic carotid plaques (Schmidt et
al 2003). Finally, Honda et al (2004) showed that echolucent
carotid plaques predict coronary plaque complexity and the
development of future coronary complications in patients
with stable coronary artery disease. These studies, however,
have some potential limitations. In the studies of Liapis et
al (2002) and Schmidt et al (2003), the combined end points
were used, and therefore, conclusions with regard to
cardiovascular events only could not be made. Honda et al
(2004) compared patients with echolucent carotid plaques
with patients without carotid disease and patients with
echogenic carotid plaques taken together. Such combination
masked the risk associated with echogenic carotid plaques.
Moreover, the overall prevalence of carotid disease in stable
CAD patients was very high (79%), as was the prevalence
of echolucent carotid plaques (52%).
Conversely, it has been shown that in patients with acute
coronary syndromes, either echogenic or echolucent carotid
plaques are associated with lower event-free survival
regardless of the treatment strategy (conservative treatment
or myocardial revascularization) (Komorovsky et al 2005).
However, the presence of echogenic carotid plaques
appeared to be an independent predictor of cardiac death
and nonfatal myocardial infarction in these patients.
Echogenic carotid plaques, when associated with complex
coronary lesions, were associated with a particularly poor
long-term event-free survival (Komorovsky et al 2005). One
of the links that explain the associations between echogenic
carotid plaques and cardiac events might be increased arterial
stiffness, which is observed in patients with echogenic
carotid plaques (Zureik et al 2003) and which, by itself, is
associated with adverse cardiovascular outcomes
(Boutouyrie et al 2002). Echogenic carotid plaques might
also reflect the total burden of calcium and of athero-
sclerosis, including that of the coronary arteries (Nossen et
al 2001). The amount of coronary calcium and the fast
progression of coronary calcifications, revealed by electron
beam tomographic and multidetector scanning, has been
previously associated with a greater risk of cardiovascular
events (O’Rourke et al 2000; Keelan et al 2001). Finally,
carotid calcifications may also reflect a diffuse coronary
disease. The extent of non-obstructive atherosclerotic lesions
has been found to be a strong predictor of coronary events,
independent of severity and the number of flow-limiting
coronary lesions (Bigi et al 2003).
These data, however, do not completely resolve the
existing controversy. Recent observations have suggested
that inflammation may be a possible link between coronary
and carotid plaque instability (Lombardo et al 2004).
Complex carotid plaques were detected more frequently in
patients with CAD and elevated serum C-reactive protein
(> 3 mg/L) compared with patients with normal C-reactive
protein levels. It may be that the degree of generalized
inflammation, as reflected by C-reactive protein level,
determines the echolucent plaque instability and the
associated adverse outcomes. Moreover, higher interleukin-
6 and high-sensitivity C-reactive protein levels have been
recently shown to be associated with lower echogenicity of
carotid plaques (Yamagami et al 2004). These data are in
contradiction with the previous studies, which failed to
demonstrate significant associations between echolucency
of carotid plaques and acute phase reactants such as
fibrinogen (Kofoed et al 2003), C-reactive protein,
orsomucoid (Grønholdt, Silesen, et al 2001), and intra-
cellular adhesion molecule-1 (Okulla et al 2002). Although
the acute phase reactants reflect the general inflammation
and may not be significantly modulated by changes in the
carotid arteries (Grønholdt, Silesen, et al 2001), we suggest
that echolucent plaques in patients with inflammation might
have a different risk than echolucent plaques without evident
signs of inflammation. In support of this, there is increasingVascular Health and Risk Management 2005:1(2) 135
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evidence that acute phase reactants, especially C-reactive
protein, are not just the markers of inflammation but also
active participants of the formation process of atherosclerotic
plaques (Zwaka et al 2001; Fu and Borensztajn 2002).
Clinical implications
A high prevalence of carotid disease in patients with CAD
and the associated risks imply that screening for carotid
atherosclerosis should be considered in all patients with
diagnosed CAD. The detection of carotid disease may
modify treatment strategy of these patients; eg, more
aggressive medical therapy in case of subclinical carotid
atherosclerosis, combined coronary and carotid surgery for
patients with critical stenoses in both territories, and staged
operations.
Conclusions
1. Intima-media thickness may be used for cardiovascular
risk assessment in patients at intermediate risk of CAD.
2. The presence of carotid plaques is associated with an
increased risk of cardiovascular events in patients with
CAD, regardless of the treatment strategy (medical
therapy alone or myocardial revascualrization).
3. The prognostic relevance of ultrasound characteristics
of carotid plaques in patients with CAD, possibly in
association with inflammatory markers, needs to be
further clarified.
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